LIP AND ORAL CAVITY: Incisional Biopsy, Excisional Biopsy, Resection Specimen: Vermilion border upper lip Vermilion border lower lip Mucosa of upper lip Mucosa of lower lip Commissure of lip Lateral border of tongue Ventral surface of tongue, not otherwise specified (NOS) Dorsal surface of tongue, NOS Anterior two-thirds of tongue, NOS Upper gingiva (gum) Lower gingiva (gum) Anterior floor of mouth Floor of mouth, NOS Hard palate Buccal mucosa (inner cheek) Vestibule of mouth: Upper Lower Alveolar process: Upper Lower Mandible Maxilla Other (specify): Not specified Received: Fresh In formalin Other (specify): Procedure Type: Incisional biopsy Excisional biopsy Resection: Glossectomy (specify): Mandibulectomy (specify): Maxillectomy (specify): Palatectomy Neck (lymph node) dissection (specify): Other (specify): Not specified Specimen Integrity: Intact Fragmented Specimen Size: Greatest dimensions (cm): Additional dimensions (if more than one part) (cm): Specimen Laterality: Right Left Bilateral Midline Not specified Tumor Site: Vermilion border upper lip Vermilion border lower lip Mucosa of upper lip Mucosa of lower lip Commissure of lip Lateral border of tongue Ventral surface of tongue, NOS Dorsal surface of tongue, NOS Anterior two-thirds of tongue, NOS Upper gingiva (gum) Lower gingiva (gum) Anterior floor of mouth Floor of mouth, NOS Hard palate Buccal mucosa (inner cheek) Vestibule of mouth: Upper Lower Alveolar process: Upper Lower Mandible Maxilla Other (specify): Not specified Tumor Focality: Single focus Multifocal (specify): Tumor Size: Greatest dimension (cm): Additional dimensions: x cm Cannot be determined: Tumor Thickness (pT1 and pT2 tumors)Tumor thickness (mm): Intact surface mucosa: Ulcerated surface: Tumor Description Gross subtype: Polypoid Exophytic Endophytic Ulcerated Sessile Other (specify): Macroscopic Extent of Tumor: Histologic Type: Squamous cell carcinoma, conventional Variants of Squamous Cell Carcinoma: Acantholytic squamous cell carcinoma Adenosquamous carcinoma Basaloid squamous cell carcinoma Carcinoma cuniculatum Papillary squamous cell carcinoma Spindle cell squamous carcinoma Verrucous carcinoma Lymphoepithelial carcinoma (non-nasopharyngeal) Carcinomas of Minor Salivary Glands : Acinic cell carcinoma Adenoid cystic carcinoma Adenocarcinoma, not otherwise specified (NOS): Low grade Intermediate grade High grade Basal cell adenocarcinoma Carcinoma ex pleomorphic adenoma (malignant mixed tumor): Low-grade High-grade Invasive: Minimally invasive Invasive Intracapsular (noninvasive) Carcinoma, type cannot be determined Carcinosarcoma Clear cell adenocarcinoma Cystadenocarcinoma Epithelial-myoepithelial carcinoma Mucoepidermoid carcinoma: Low grade Intermediate grade High grade Mucinous adenocarcinoma (colloid carcinoma) Myoepithelial carcinoma (malignant myoepithelioma) Oncocytic carcinoma Polymorphous low-grade adenocarcinoma Salivary duct carcinoma Other (specify): Adenocarcinoma, Non-Salivary Gland Type: Adenocarcinoma, not otherwise specified (NOS): Low grade Intermediate grade High grade Other (specify): Neuroendocrine Carcinoma: Typical carcinoid tumor (well differentiated neuroendocrine carcinoma) Atypical carcinoid tumor (moderately differentiated neuroendocrine carcinoma) Small cell carcinoma (poorly differentiated neuroendocrine carcinoma) Combined (or composite) small cell carcinoma, neuroendocrine type Other (specify): Carcinoma, type cannot be determined Mucosal malignant melanoma Histologic Grade: Not applicable GX: Cannot be assessed G1: Well differentiated G2: Moderately differentiated G3: Poorly differentiated Other (specify): Microscopic Tumor Extension: Margins: Cannot be assessed Margins uninvolved by invasive carcinoma, distance from closest margin: at Margins involved by invasive carcinoma at Margins uninvolved by carcinoma in situ (includes moderate and severe dysplasia), distance from closest margin: at Margins involved by carcinoma in situ (includes moderate and severe dysplasia) at Not applicable Treatment Effect (applicable to carcinomas treated with neoadjuvant therapy): Not identified Present (specify): Indeterminate Lymph-Vascular Invasion: Not identified Present Indeterminate Perineural Invasion: Not identified Present Indeterminate Lymph Nodes, Extranodal Extension: Not identified Present Indeterminate Pathologic Staging (pTNM): TNM Descriptors:m (multiple primary tumors) r (recurrent) y (post-treatment) Primary Tumor (pT):Non-mucosal malignant melanoma pTX: Cannot be assessed pT0: No evidence of primary tumor pTis: Carcinoma in situ pT1: Tumor 2 cm or less in greatest dimension pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension pT3: Tumor more than 4 cm in greatest dimension pT4a: Moderately advanced local disease. (Lip: Tumor invades through cortical bone, inferior alveolar nerve, floor of mouth, or skin of face, ie, chin or nose; Oral cavity: Tumor invades adjacent structures only (eg, through cortical bone mandible, maxilla, into deep extrinsic muscle of tongue genioglossus, hyoglossus, palatoglossus, and styloglossus, maxillary sinus, skin of face)) pT4b: Very advanced local disease. Tumor invades masticator space, pterygoid plates, or skull base, and/or encases internal carotid artery (Note: Superficial erosion alone of bone/tooth socket by gingival primary is not sufficient to classify a tumor as T4.) Mucosal Malignant Melanoma pT3: Mucosal disease pT4a: Moderately advanced disease. Tumor involving deep soft tissue, cartilage, bone, or overlying skin pT4b: Very advanced disease. Tumor involving brain, dura, skull base, lower cranial nerves (IX, X, XI, XII), masticator space, carotid artery, prevertebral space, or mediastinal structures Regional Lymph Nodes (pN):Non-mucosal malignant melanoma pNX: Cannot be assessed pN0: No regional lymph node metastasis ( 0 / ) pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension ( 1 / ) pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension ( 1 / ) pN2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension ( / ) pN2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension ( / ) pN3: Metastasis in a lymph node more than 6 cm in greatest dimension ( / ) Mucosal Malignant Melanoma pNX: Regional lymph nodes cannot be assessed pN0: No regional lymph node metastases ( 0 / ) pN1: Regional lymph node metastases present ( / ) Size (greatest dimension) of the largest positive lymph node (cm): Superior mediastinal lymph nodes are considered regional lymph nodes (level VII). Midline nodes are considered ipsilateral nodes.Distant Metastasis (pM): Not Applicable pM1: Distant metastasis: Specify site(s), if known; Specify source of pathologic metastatic specimenAdditional Pathologic Findings: None identified Keratinizing dysplasia: Mild Moderate Severe (carcinoma in situ) Non-keratinizing dysplasia: Mild Moderate Severe (carcinoma in situ) Inflammation (specify type): Epithelial hyperplasia Colonization: Fungal Bacterial Other (specify): Ancillary Studies: Treatment History: Neoadjuvant therapy: Yes: No Indeterminate Other (specify): Comment(s):